Immatics NV (IMTX)
10.77
-0.12
(-1.10%)
USD |
NASDAQ |
May 03, 16:00
10.78
+0.01
(+0.09%)
After-Hours: 20:00
Immatics Cash and Short Term Investments (Quarterly): 470.78M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 470.78M |
| September 30, 2023 | 387.43M |
| June 30, 2023 | 377.78M |
| March 31, 2023 | 359.64M |
| December 31, 2022 | 388.43M |
| September 30, 2022 | 304.04M |
| June 30, 2022 | 338.84M |
| March 31, 2022 | 282.09M |
| Date | Value |
|---|---|
| December 31, 2021 | 164.30M |
| September 30, 2021 | 200.91M |
| June 30, 2021 | 229.44M |
| March 31, 2021 | 253.98M |
| December 31, 2020 | 285.32M |
| September 30, 2020 | 304.43M |
| June 30, 2020 | 96.78M |
| December 31, 2019 | 133.72M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
96.78M
Minimum
Jun 2020
470.78M
Maximum
Dec 2023
286.12M
Average
294.68M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| MorphoSys AG | 754.72M |
| Affimed NV | 80.58M |
| InflaRx NV | 99.79M |
| BioNTech SE | 18.29B |
| CureVac NV | 447.81M |